Detection & analytical chemistry

The short answer

What forensic labs are seeing

SR-17018 has been detected in the unregulated opioid supply alongside related orphine analogs. The Center for Forensic Science Research and Education (CFSRE) and similar bodies have issued public alerts noting that, as analytical reference standards have become more available, multiple orphine-class compounds are being identified in seized drug materials[1].

Compounds named in CFSRE alerts include:

• Chlorphine
• N-propionitrile chlorphine (cychlorphine)
• 5,6-dichloro desmethylchlorphine — a name applied to SR-17018 in some forensic alerts
• Spirochlorphine
• Spirobrorphine
• 5,6-dichloro brorphine (SR-14968)

What this means in practice

• SR-17018 will not appear on standard hospital or workplace immunoassay opioid panels.
• Forensic confirmation generally requires LC–MS/MS or LC–HRMS with appropriate reference standards.
• Identification in postmortem casework may be limited by the absence of the compound in many laboratories' target lists. This means SR-17018-attributable harm could be under-counted in toxicology databases.

For research labs and reagent vendors

SR-17018 reference standards are commercially available (e.g., MedKoo, Cayman Chemical) for in vitro work. Forensic labs adding the compound to their target list should source standards from a reputable supplier and validate identification using both retention time and a full MS/MS spectrum.